Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	P2B001	0	150
Total, all-cause mortality	Rasagiline Capsule	0	147
Total, all-cause mortality	Pramipexole Capsule	0	148
Total, all-cause mortality	Pramipexole Extended Release	0	74
Total, other adverse events	P2B001	78	150
Total, other adverse events	Rasagiline Capsule	52	147
Total, other adverse events	Pramipexole Capsule	86	148
Total, other adverse events	Pramipexole Extended Release	54	74
Total, serious adverse events	P2B001	3	150
Total, serious adverse events	Rasagiline Capsule	2	147
Total, serious adverse events	Pramipexole Capsule	3	148
Total, serious adverse events	Pramipexole Extended Release	0	74

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03329508/event-totals